Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #1

    edgeR multiple testing

    Hi everybody,

    I've searched a lot but have not found a definitive discussion on this yet.

    I'm using edgeR on a human dataset with 3-4 replicates per group.

    When I follow the edgeR tutorial and export (see code below) I get this:

    Code:
    dispersion = estimateCommonDisp(DGE_timepoints)
    de.com <- exactTest(dispersion, c("healthy-control","disease"))
    out_tags1 = topTags(de.com, n=length(de.com))
    write.table(out_tags1, "out_unadjusted_pvalue.csv", sep="\t")

    gene table.logConc table.logFC table.PValue table.FDR adjust.method
    ENSG00000250644 -20.0951079864 -11.2384935084 1.19615633839674e-08 0.0002112173 BH
    ENSG00000176994 -33.1995219248 -33.633064638 1.27917856074067e-07 0.0009680458 BH

    Note that adjust method is BH, but I am not sure if Pvalue adjustment was carried out by default. In the manual it seems to suggest a further Pvalue adjustment is needed:

    Code:
    # P values adjusted by Benjani-Hochberg method, single column
    out_tags_adjusted = p.adjust(de.com$table$p.value, method="BH")
    
    write.table(out_tags_adjusted, "out_adjusted_pvalue.csv", sep="\t")
    However, the two top results above then get an "adjusted" Pvalue of 1 and 0.3 respectively, and virtually no hits are significantly differently regulated.

    I guess that the initial step is sufficient to implement multiple testing.
    Comments?
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #2
    You don't need to do any more adjustment. The adjusted values are in the column which is called 'table.FDR'.

    Comment

    • colindaven
      Senior Member
      • Oct 2008
      • 417

      #3
      Ah I see. Thanks for the help!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...